CN Stock MarketDetailed Quotes
688506 Sichuan Biokin Pharmaceutical
- 197.76
- +5.58+2.90%
Market Closed Nov 8 15:00 CST
79.30BMarket Cap20.87P/E (TTM)
202.99High193.02Low16.34KlotVolume199.00Open192.18Pre Close325.25MTurnover1.81%Turnover RatioLossP/E (Static)401.00MShares238.8052wk High18.70P/B17.89BFloat Cap90.3152wk Low230.62Limit Up90.45MShs Float238.80Historical High153.74Limit Down5.19%Amplitude28.75Historical Low--Dividend TTM199.04Avg Price7.24KlotAsk--Div YieldTTM100Lot Size7.59KlotBid
Sichuan Biokin Pharmaceutical Key Stats
EPS
According to the latest financial report of Sichuan Biokin Pharmaceutical, the latest earnings per share (TTM) for the company is 10.14. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Sichuan Biokin Pharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 10.58.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Sichuan Biokin Pharmaceutical shows that the company's current ratio is 2.97, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Sichuan Biokin Pharmaceutical, the quick ratio is 2.89, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Sichuan Biokin Pharmaceutical? The latest ROE figure is 185.05%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Sichuan Biokin Pharmaceutical, the total asset return on investment (ROA) is 96.96%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Sichuan Biokin Pharmaceutical's latest financial report to see how their gross margin is doing - currently at 96.90%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Sichuan Biokin Pharmaceutical, the net profit margin is 71.79%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data